Floatz logo

FLUDROCORTISONE

Congenital Adrenal Hyperplasia

University of Texas Southwestern Medical CenterSmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Congenital Adrenal Hyperplasia cohort.

Asset / SponsorPhaseRating
Hydrocortisone
University of Texas Southwestern Medical Center
Phase 4A
Cortisone
Federico II University
Phase 4BBB
Atumelnant
Crinetics Pharmaceuticals Inc.
Phase 3BB
Dexasone
Shanghai Jiao Tong University School of Medicine
Phase 4BB
Crinecerfont
Neurocrine Biosciences
Phase 3BB

View all 18 →

Same molecule, other indications

FLUDROCORTISONE is also rated in:

Parkinson diseaseDormant
BB
Indicative · Phase 2
64 / 100
View asset →
castration-resistant prostate carcinomaActive
B
Indicative · Phase 3
59 / 100
View asset →
prostate neoplasmActive
B
Indicative · Phase 3
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →